Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 (a Low Volume Bowel Cleansing Solution) Versus MOVIPREP Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults.

NCT02273167 is registered in ClinicalTrials.gov with Norgine as lead sponsor.

NCT NCT02273167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02273167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 (a Low Volume Bowel Cleansing Solution) Versus MOVIPREP Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults.
Lead sponsor
Norgine
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2014
Completion date
August 31, 2015
Enrollment
849 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

colon cleansing, colorectal cancer, colorectal carcinoma